DiscoverCanadian Urological Association (CUA)Luke Lavallee | Bone Health Management in Prostate Cancer | Q&A Series
Luke Lavallee | Bone Health Management in Prostate Cancer | Q&A Series

Luke Lavallee | Bone Health Management in Prostate Cancer | Q&A Series

Update: 2022-04-20
Share

Description

Sponsored by Amgen.

Luke Lavallee
Urologic Oncologist and Associate Scientist
The Ottawa Hospital
Ottawa Hospital Research Institute

Disclosures:
Advisory Board: Sanofi, Ferring, Knight, Bayer, Janssen, Astellas
Grant/Honorarium: Sanofi

Comments 
In Channel
Canadian Expert discussion on the treatment and management considerations for MIBC treatment regimens

Canadian Expert discussion on the treatment and management considerations for MIBC treatment regimens

2025-03-0430:20

Canadian Expert discussion on optimizing RCC treatment

Canadian Expert discussion on optimizing RCC treatment

2023-11-2942:13

2 Pees In A Pod Podcast - Ep 4 - Introduction to bladder cancer

2 Pees In A Pod Podcast - Ep 4 - Introduction to bladder cancer

2023-10-1922:44

2 Pees In A Pod Podcast - Ep 3 - Urinary tract infections in women

2 Pees In A Pod Podcast - Ep 3 - Urinary tract infections in women

2023-10-1124:07

2 Pees In A Pod Podcast - Ep 2 - Male voiding disorders and Benign Prostatic Hyperplasia (BPH)

2 Pees In A Pod Podcast - Ep 2 - Male voiding disorders and Benign Prostatic Hyperplasia (BPH)

2023-10-0432:19

2 Pees In A Pod Podcast - Ep 1 - PSA and Prostate Cancer Screening

2 Pees In A Pod Podcast - Ep 1 - PSA and Prostate Cancer Screening

2023-09-2728:57

CUA Highlights of ESMO 2022 - Kidney Cancer Session - French

CUA Highlights of ESMO 2022 - Kidney Cancer Session - French

2022-10-0143:48

CUA Highlights of ESMO 2022 - Kidney Cancer Session - English

CUA Highlights of ESMO 2022 - Kidney Cancer Session - English

2022-10-0143:50

CUA Highlights of ESMO 2022 - Bladder Cancer Session - French

CUA Highlights of ESMO 2022 - Bladder Cancer Session - French

2022-10-0141:08

CUA Highlights of ESMO 2022 - Bladder Cancer Session - English

CUA Highlights of ESMO 2022 - Bladder Cancer Session - English

2022-10-0141:47

CUA Highlights of ESMO 2022 - Prostate Cancer Session - French

CUA Highlights of ESMO 2022 - Prostate Cancer Session - French

2022-10-0144:45

CUA Highlights of ESMO 2022 - Prostate Cancer Session - English

CUA Highlights of ESMO 2022 - Prostate Cancer Session - English

2022-10-0144:44

Jean Gregoire | CV Risk | Q&A Series - French

Jean Gregoire | CV Risk | Q&A Series - French

2022-04-2104:35

Fred Saad | CV Risk | Q&A Series - French

Fred Saad | CV Risk | Q&A Series - French

2022-04-2104:44

Darryl Leong | CV Risk | Q&A Series

Darryl Leong | CV Risk | Q&A Series

2022-04-2112:19

Fred Saad | CV Risk | Q&A Series

Fred Saad | CV Risk | Q&A Series

2022-04-2105:21

Jean Gregoire | CV Risk | Q&A Series

Jean Gregoire | CV Risk | Q&A Series

2022-04-2105:28

Luke Lavallee | Bone Health Management in Prostate Cancer | Q&A Series

Luke Lavallee | Bone Health Management in Prostate Cancer | Q&A Series

2022-04-2007:13

Sophie Mottard | Bone Health Management in Prostate Cancer | Q&A Series

Sophie Mottard | Bone Health Management in Prostate Cancer | Q&A Series

2022-04-2020:14

David Kendler | Bone Health Management in Prostate Cancer | Q&A Series

David Kendler | Bone Health Management in Prostate Cancer | Q&A Series

2022-04-2015:21

loading
Google Play
Download from Google Play
Castbox
Download from App Store
usUnited States
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Luke Lavallee | Bone Health Management in Prostate Cancer | Q&A Series

Luke Lavallee | Bone Health Management in Prostate Cancer | Q&A Series

Luke Lavallee